Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles A. Leonard.
Progress in Neuro-psychopharmacology | 1979
David N. Johnson; Brenda Turley; Mary R. Jones; Cynthia B. Coffin; Charles A. Leonard; William H. Funderburk
1. AHR-6646 blocked d-amphetamine lethality in mice under aggregated conditions when the pretreatment interval was between one hour and seven days. 2. Conditioned avoidance responding in mice and cats was suppressed by AHR-6646 in doses that did not impair escape behavior. The duration of this effect was markedly prolonged. 3. AHR-6646 produced catalepsy in rats. The onset of this effect was delayed and the duration was prolonged when compared with that of chlorpromazine. 4. Apomorphine-induced pivoting in mice with unilateral lesions of the caudate nucleus was suppressed by AHR-6646. 5. AHR-6646 was a potent antiemetic agent in dogs, with a delayed onset and prolonged duration of action.
Journal of Medicinal Chemistry | 1989
Albert D. Cale; Thomas W. Gero; Kathleen R. Walker; Young S. Lo; William J. Welstead; Larry W. Jaques; Ashby F. Johnson; Charles A. Leonard; Joseph C. Nolan; David N. Johnson
Archive | 1974
Albert D. Cale; Charles A. Leonard
Journal of Pharmacology and Experimental Therapeutics | 1966
Charles A. Leonard; Tsuneo Fujita; David H. Tedeschi; Charles L. Zirkle; Edwin J. Fellows
Archive | 1983
Albert D. Cale; Bernard V. Franko; Charles A. Leonard
Archive | 1985
Charles A. Leonard; Bernard V. Franko; Albert D. Cale
Journal of Medicinal Chemistry | 1970
Carl Kaiser; Charles A. Leonard; George C. Heil; Bruce M. Lester; David H. Tedeschi; Charles L. Zirkle
Archive | 1976
Albert D. Cale; Charles A. Leonard
Archive | 1984
Charles A. Leonard; Bernard V. Franko; Cale Albert Duncan
Archive | 1983
Albert D. Cale; Bernard V. Franko; Charles A. Leonard